Borealis Ventures

bringing together the elements to build visionary healthcare companies

[Borealis Ventures @BorealisVC]

Congratulations to the Avitide team!

[Repligen @Repligen]

Repligen today announced it has entered into a definitive agreement to acquire Avitide. The proposed acquisition adds a market leader in affinity ligand discovery/development and strategically moves Repligen into affinity resin solutions for #GeneTherapy . https://t.co/cvdzlDOI6Q

[Borealis Ventures @BorealisVC]

@OrbitDiscovery announces $7.6M in funding to accelerate growth in peptide discovery business. #peptidediscovery https://t.co/MyQHuIr2v2

[Borealis Ventures @BorealisVC]

Delighted to participate in Evox Therapeutics' Series C to continue advancing its pipeline of exosome therapeutics. https://t.co/LPZk9p06mp

[Borealis Ventures @BorealisVC]

Outstanding work by Avitide to improve efficiency of COVID-19 vaccine manufacturing. https://t.co/upSCu5ebwt

[Borealis Ventures @BorealisVC]

We're thrilled to partner with @Ovation_io on their Series B as they continue on their mission to transform the future of lab software — connecting researchers with insights that can deliver personalized medicines faster.
https://t.co/KombIJTSkU

[Borealis Ventures @BorealisVC]

Evox Therapeutics announces strategic collaboration with the University of Oxford. #exosomes https://t.co/6ws2ZldXL9

[Borealis Ventures @BorealisVC]

@ovation_io launches pooled testing to bolster COVID-19 offering and support return to campus and return to work initiatives #coronavirustesting https://t.co/hNIYtRfy22

[Borealis Ventures @BorealisVC]

@teckroofficial welcomes Amanda Buckley as Chief Operating Officer and celebrates 5 years of delivering answers to study stakeholders anywhere, anytime. https://t.co/CjpZrbxJr0

[Borealis Ventures @BorealisVC]

Adimab spins out Adagio Therapeutics to develop broadly protective coronavirus antibodies. #coronavirus https://t.co/DDSBvPHkuL

[Borealis Ventures @BorealisVC]

Evox Therapeutics granted key patent for exosomes loaded with nucleic acid-based therapeutics. #exosomes
https://t.co/XPqhg5juGO

[Borealis Ventures @BorealisVC]

Congrats to Compass Therapeutics for completing a $60M financing to advance a new generation of antibody therapies through clinical development. https://t.co/iDn1GHV9xb

[Borealis Ventures @BorealisVC]

Congrats to the Evox team as they announce a multi-target collaboration with Lilly in neurological disorders. #exosomes https://t.co/NdcgP3QMbH

[Borealis Ventures @BorealisVC]

Another great addition to the Evox Therapeutics board. #exosomes #raredisease https://t.co/CnGtIv4JTj

[Borealis Ventures @BorealisVC]

Evox Therapeutics welcomes Dr. Sonya Montgomery as Chief Medical Officer. #exosomes #raredisease https://t.co/qy9EBm6zFR

[Borealis Ventures @BorealisVC]

Great work going on at @teckroofficial to provide COVID-19 clinical trial sponsors, researchers, and patients with answers anywhere, anytime. https://t.co/QagzC0RMEH

[Borealis Ventures @BorealisVC]

Compass Therapeutics' lead candidate shown to clear solid tumors in mice. https://t.co/B7RniJ9cWi

[Borealis Ventures @BorealisVC]

Congrats to the Evox Therapeutics team on signing a multi-target collaboration with @TakedaPharma to leverage their exosome technology for rare disease therapeutics. #raredisease #exosome https://t.co/Wl5Wrtww2L

[Borealis Ventures @BorealisVC]

We are proud to stand with @Ovation_io, who today announced an initiative that could double testing capacity for COVID-19 across the United States. https://t.co/6hJd9Mc510 #coronavirustesting

[Borealis Ventures @BorealisVC]

More exciting news for @Avitide in announcing a partnership expansion with @Allergan. #bioprocessing #affinitypurification https://t.co/8ouDm4t5No

[Borealis Ventures @BorealisVC]

Exciting announcement for
@Avitide on their partnership with Gemini Therapeutics! #bioprocess #affinitypurification
https://t.co/kdKZ80Ythf